Aventis--World's No. 1 Drugmaker Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aventis--World's No. 1 Drugmaker

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

To: Mike McFarland who wrote ()	7/19/1999 1:47:00 PM
From: Mike McFarland	Read Replies (1) of 22

News items today: I am not going to post urls every day...there are just too many for Rhone and Hoecsts...but I did at least want to get the thread started. Juergen Dormann, wants to remain at the helm for at least five years after the company's merger with France's Rhone-Poulenc dailynews.yahoo.com Nanogen and Aventis Research & Technologies (A Subsidiary of Hoechst AG) Achieve Research Milestones biz.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext